CSIMarket
 


China Pediatric Pharmaceuticals, Inc.  (CPDU)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

CPDU's Revenue Growth by Quarter and Year

China Pediatric Pharmaceuticals,'s Revenue results by quarter and year




CPDU Revenue (in millions $) FY 2014 FY 2013 FY 2012 FY 2011
IV Quarter December - 1.12 1.21 0.00
III Quarter September - 0.79 1.96 0.00
II Quarter June - 0.94 6.16 0.00
I Quarter March 1.58 0.88 4.83 0.00
FY   1.58 3.73 14.16 0.00



CPDU Revenue first quarter 2014 Y/Y Growth Comment
China Pediatric Pharmaceuticals, Inc. achieved in the first quarter 2014, above Company average Revenue rise of 79.68% year on year, to $ 1.58 millions.

Looking into first quarter 2014 results within Healthcare Facilities industry 2 other companies have achieved higher Revenue growth. While China Pediatric Pharmaceuticals, Inc.' s Revenue jump of 79.68% ranks overall at the positon no. 234 in the first quarter 2014.




CPDU Revenue ( Y/Y Growth %) 2014
2013 2012 2011
IV Quarter December - -7.44 % - -
III Quarter September - -59.69 % - -
II Quarter June - -84.74 % - -
I Quarter March 79.68 % -81.78 % - -
FY   - -73.66 % - -

Financial Statements
China Pediatric Pharmaceuticals,'s first quarter 2014 Revenue $ 1.58 millions CPDU's Income Statement
China Pediatric Pharmaceuticals,'s first quarter 2013 Revenue $ 0.88 millions Quarterly CPDU's Income Statement
New: More CPDU's historic Revenue Growth >>


CPDU Revenue (Quarter on Quarter Growth %)

2014
2013 2012 2011
IV Quarter December - 41.77 % -38.27 % -
III Quarter September - -15.96 % -68.18 % -
II Quarter June - 6.82 % 27.54 % -
I Quarter March 41.18 % -27.27 % - -
FY (Year on Year)   - -73.66 % - -




Revenue first quarter 2014 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #3
Healthcare Sector #56
Overall #234

Revenue Y/Y Growth Statistics
High Average Low
79.17 % -30.95 % -84.82 %
(Mar 31 2014)   (Jun 30 2013)
Revenue first quarter 2014 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #3
Healthcare Sector #56
Overall #234
Revenue Y/Y Growth Statistics
High Average Low
79.17 % -30.95 % -84.82 %
(Mar 31 2014)   (Jun 30 2013)

Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

China Pediatric Pharmaceuticals,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
42.83 % -4.05 % -68.18 %
(Dec 31 2013)  


CPDU's I. Quarter Q/Q Revenue Comment
China Pediatric Pharmaceuticals, Inc. achieved in the I. Quarter 2014 above company average sequential Revenue jump of 41.18%, to $ 1.58 millions, from $1.12 millions in the fourth quarter.

Within Healthcare Facilities industry 5 other companies have achieved higher Revenue quarter on quarter growth. While China Pediatric Pharmaceuticals,'s Revenue growth quarter on quarter, overall rank is 279.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #6
Healthcare Sector #44
Overall #279
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #6
Healthcare Sector #44
Overall #279
Revenue Q/Q Growth Statistics
High Average Low
42.83 % -4.05 % -68.18 %
(Dec 31 2013)  


CPDU's I. Quarter Q/Q Revenue Comment
China Pediatric Pharmaceuticals, Inc. achieved in the I. Quarter 2014 above company average sequential Revenue jump of 41.18%, to $ 1.58 millions, from $1.12 millions in the fourth quarter.

Within Healthcare Facilities industry 5 other companies have achieved higher Revenue quarter on quarter growth. While China Pediatric Pharmaceuticals,'s Revenue growth quarter on quarter, overall rank is 279.


China Pediatric Pharmaceuticals,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2014)
12 Months Ending
(Dec 31 2013)
12 Months Ending
(Sep 30 2013)
12 Months Ending
(Jun 30 2013)
12 Months Ending
(Mar 31 2013)
Cumulative Revenue 12 Months Ending $ 4.42 $ 3.73 $ 3.82 $ 4.99 $ 10.22
Y / Y Revenue Growth (TTM) -56.69 % -73.7 % - - -
Year on Year Revenue Growth Overall Ranking # 3026 # 3028 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 18.75 % -2.36 % -23.53 % -51.15 % -27.89 %
Seq. Revenue Growth (TTM) Overall Ranking # 183 # 178 # 0 # 0 # 2526




Cumulative Revenue growth Comment
China Pediatric Pharmaceuticals, showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2013. If the fiscal year would end in Mar 31 2014, China Pediatric Pharmaceuticals,'s annual Revenue drop would be -56.69% year on year to $4 millions.

In the Healthcare sector 322 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 3026, from total ranking in previous quarter at 3028.

Revenue TTM Q/Q Growth Statistics
High Average Low
18.75 %
8.19 %
-2.36 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 3
Healthcare Sector # 323
Overall # 3026

Revenue TTM Y/Y Growth Statistics
High Average Low
-56.69 %
-65.19 %
-73.7 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 35
S&P 500 # 183
Cumulative Revenue growth Comment
China Pediatric Pharmaceuticals, showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2013. If the fiscal year would end in Mar 31 2014, China Pediatric Pharmaceuticals,'s annual Revenue drop would be -56.69% year on year to $4 millions.

In the Healthcare sector 322 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 3026, from total ranking in previous quarter at 3028.

Revenue TTM Q/Q Growth Statistics
High Average Low
18.75 %
8.19 %
-2.36 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 3
Healthcare Sector # 323
Overall # 3026

Revenue TTM Y/Y Growth Statistics
High Average Low
-56.69 %
-65.19 %
-73.7 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 35
S&P 500 # 183




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CPDU's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CPDU's Competitors
Revenue Growth for China Pediatric Pharmaceuticals,'s Suppliers
Revenue Growth for CPDU's Customers

You may also want to know
CPDU's Annual Growth Rates CPDU's Profitability Ratios CPDU's Asset Turnover Ratio CPDU's Dividend Growth
CPDU's Roe CPDU's Valuation Ratios CPDU's Financial Strength Ratios CPDU's Dividend Payout Ratio
CPDU's Roa CPDU's Inventory Turnover Ratio CPDU's Growth Rates CPDU's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Mar 31 2014 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2014
Vaxart Inc 136.08%$ 136.076 millions
Cryoport inc 126.85%$ 126.855 millions
Musclepharm Corporation122.55%$ 122.548 millions
Athersys Inc116.87%$ 116.871 millions
Pacific Biosciences Of California Inc 108.71%$ 108.713 millions
Lannett Company Inc105.00%$ 105.005 millions
Gilead Sciences Inc 97.46%$ 97.460 millions
Novavax inc94.68%$ 94.678 millions
Protalix Biotherapeutics inc 87.67%$ 87.668 millions
Cyclacel Pharmaceuticals Inc 86.79%$ 86.792 millions
Teligent Inc 86.07%$ 86.071 millions
Therapeuticsmd Inc 84.14%$ 84.136 millions
Bioxytran Inc 82.29%$ 82.292 millions
Enanta Pharmaceuticals Inc80.60%$ 80.602 millions
China Pediatric Pharmaceuticals, Inc.79.17%$ 79.173 millions
Standard Biotools Inc 76.98%$ 76.980 millions
Fibrocell Science, Inc.76.92%$ 76.923 millions
Sangamo Therapeutics Inc 75.56%$ 75.557 millions
Aethlon Medical Inc 74.84%$ 74.837 millions
Achari Ventures Holdings Corp I74.63%$ 74.629 millions
Lineage Cell Therapeutics Inc 73.59%$ 73.585 millions
Tearlab Corp70.14%$ 70.141 millions
Mimedx Group Inc 69.25%$ 69.248 millions
Dynavax Technologies Corporation67.77%$ 67.770 millions
Alexion Pharmaceuticals Inc 67.17%$ 67.172 millions
Tenet Healthcare Corp64.47%$ 64.474 millions
Inovio Pharmaceuticals Inc 62.01%$ 62.012 millions
Caladrius Biosciences Inc 60.69%$ 60.686 millions
Acer Therapeutics Inc 58.49%$ 58.490 millions
Grapefruit Usa Inc 55.86%$ 55.862 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com